FallberichtOpen Access · CC BY 4.0
The treatment of bullous pemphigoid with topical roflumilast 0.3% cream case study
JAAD Case Reports · 2026-04 · 70 · 149-151
DOI: 10.1016/j.jdcr.2026.02.005 ↗Kurz gefasst
Fallbericht in der Zeitschrift JAAD Case Reports, 2026-04. Verfasst von Erik Domingues. Beteiligte Einrichtung: Modern Dermatology of Massachusetts, Fall River, Massachusetts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
PDE-4 inhibitorautoimmune blistering disorderbullaebullous pemphigoid (BP)erosionsphosphodiesterase-4 (PDE-4) inhibitorroflumilast cream 0.3%topical
Autor:innen und Institutionen
- Modern Dermatology of Massachusetts, Fall River, Massachusetts.
- Department of Dermatology, Assistant Professor, University of Massachusetts Chan Medical School, Worcester Massachusetts.
Zitieren
APA
Domingues, E. (2026). The treatment of bullous pemphigoid with topical roflumilast 0.3% cream case study. JAAD Case Reports, 70, 149-151. https://doi.org/10.1016/j.jdcr.2026.02.005
Vancouver
Domingues E. The treatment of bullous pemphigoid with topical roflumilast 0.3% cream case study. JAAD Case Reports. 2026;70:149-151. doi:10.1016/j.jdcr.2026.02.005
BibTeX
@article{Domingues2026,
author = {Domingues, Erik},
title = {The treatment of bullous pemphigoid with topical roflumilast 0.3% cream case study},
journal = {JAAD Case Reports},
year = {2026},
volume = {70},
pages = {149--151},
doi = {10.1016/j.jdcr.2026.02.005}
}
EUVIMED